The AHA today laid out actions the Centers for Medicare & Medicaid Services could take to immediately reduce the regulatory burden on hospitals, health systems and the patients they serve. Submitted in response to the agency’s request for information on flexibilities and efficiencies, the suggestions range from suspending the agency’s faulty hospital star ratings to cancelling Stage 3 meaningful use requirements for electronic health records and permanently prohibiting the enforcement of direction supervision requirements in critical access and small or rural hospitals. AHA is assembling a report for release later this fall that will catalogue in a holistic way the regulatory burden imposed on hospitals and health systems, the letter notes. “As one small example of the volume of recent regulatory activity: in 2016, the Centers for Medicare & Medicaid Services and other agencies of the Department of Health and Human Services released 49 hospital and health system-related rules, comprising almost 24,000 pages of text,” wrote AHA Executive Vice President Tom Nickels. “Moreover, this does not include the increasing use of sub-regulatory guidance (FAQs, blogs, etc.) to implement new administrative policies. In addition to the sheer volume, the scope of changes required by the new regulations is beginning to outstrip the field’s ability to absorb them.”

Headline
The AHA Aug. 28 shared concerns with the Centers for Medicare & Medicaid Services regarding the calendar year 2027 hospital outpatient prospective payment…
Headline
The AHA provided comments to the Centers for Medicare & Medicaid Services Aug. 28 on its calendar year 2027 home health prospective payment system proposed…
Headline
The AHA Aug. 25 submitted comments to Sen. Bill Cassidy, R-La., on the 340B Drug Pricing Integrity and Affordability for Patients Act (340B for Patients Act),…
Headline
The Department of Homeland Security today released a proposed rule to establish a new $103,265 filing fee for H-1B visa petitions that are subject to statutory…
Headline
President Trump announced Aug. 19 that he has nominated Heidi Overton to serve as the next commissioner of the Food and Drug Administration. Overton currently…
Headline
The 5th U.S. Circuit Court of Appeals Aug. 11 ruled to vacate certain regulations implementing how the No Surprises Act qualifying payment amount is calculated…